UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000037359 |
|---|---|
| Receipt number | R000042598 |
| Scientific Title | Double-blind randomized comparison of femoral triangle block and adductor canal block for total knee arthroplasty |
| Date of disclosure of the study information | 2019/07/13 |
| Last modified on | 2023/01/14 18:26:12 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Double-blind randomized comparison of femoral triangle block and adductor canal block for total knee arthroplasty
Acronym
Double-blind randomized comparison of femoral triangle block and adductor canal block for total knee arthroplasty
Scientific Title
Double-blind randomized comparison of femoral triangle block and adductor canal block for total knee arthroplasty
Scientific Title:Acronym
Double-blind randomized comparison of femoral triangle block and adductor canal block for total knee arthroplasty
Region
| Japan |
Condition
Condition
knee osteoarthritis or knee rheumatoid arthritis
Classification by specialty
| Orthopedics | Anesthesiology | Operative medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The aim is to clarify the superior efficacy of the early discharge and superior quadriceps sparing after total knee arthroplasty with administrating the femoral triangle block or the adductor canal block
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Phase III
Assessment
Primary outcomes
The ability of straight leg raise test after surgery (immediately and on postoperative day 1)
Key secondary outcomes
The attainment time of early discharge criteria
Postoperative pain score (VRS)(Postoperative 1 hour, time point per 8 hours till postoperative 72 hours)
Postoperative motor function (24, 48, 72 hours)
Postoperative rehabilitation score and muscle power(24, 48, 72 hours)
Consumption of postoperative additional analgesics(72 hours)
Complication(72 hours)
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Active
Stratification
YES
Dynamic allocation
NO
Institution consideration
Institution is not considered as adjustment factor.
Blocking
NO
Concealment
Central registration
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Maneuver |
Interventions/Control_1
Group ACB: Preoperative administration of 0.25% levobupivacaine 10 mL into the branch of femoral nerve at the apex of femoral triangle
Interventions/Control_2
Group FTB: Preoperative administration of 0.25% levobupivacaine 10 mL into the branch of femoral nerve at the midthigh level (midpoint between anterior superior iliac spine and upper edge of patella)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 100 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1.Patients scheduled unilateral total knee arthroplasty at Daiyukai General Hospital
2.Adults (>=20 years) with American Society of Anaesthesiologists Physical Status Classification I-III
3.Participants were scheduled for primary unilateral TKA for osteoarthritis
4.Written informed consent is provided
Key exclusion criteria
1.Inability to communicate lucidly
2.Bilateral TKA
3.revision knee arthroplasty
4.Under 20 years old
5.Allergy to any of the drugs used in this study
6.ASA-PS > III
7.Chronic opioid use
8.Diabetes mellitus with sensory disorders
9.Neurological disability
10.Infections around femoral crease
11.Platelet < 5.0 * 10^4 /mcl
12.Pregnancy, possibility of pregnancy, or breast-feeding women
13.Contraindications to peripheral nerve blocks
Target sample size
120
Research contact person
Name of lead principal investigator
| 1st name | Norihiro |
| Middle name | |
| Last name | Sakai |
Organization
Daiyukai General Hospital
Division name
Dep. Anaesthesiplogy
Zip code
491-8551
Address
1-9-9, Sakura, Ichinomiya, Aichi, Japan
TEL
+81-586-72-1211
sakayline@anes.med.osaka-u.ac.jp
Public contact
Name of contact person
| 1st name | Norihiro |
| Middle name | |
| Last name | Sakai |
Organization
Daiyukai General Hospital
Division name
Dep. Anaesthesiplogy
Zip code
491-8551
Address
1-9-9, Sakura, Ichinomiya, Aichi, Japan
TEL
+81-586-72-1211
Homepage URL
sakayline@anes.med.osaka-u.ac.jp
Sponsor or person
Institute
Daiyukai General Hospital
Institute
Department
Personal name
Funding Source
Organization
Daiyukai General Hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Institution of Review Board of Daiyukai general Hospital
Address
1-9-9, Sakura, Ichinomiya, Aichi, Japan
Tel
+81-586-72-1211
extensor2@yahoo.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 07 | Month | 13 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
120
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2019 | Year | 06 | Month | 01 | Day |
Date of IRB
| 2019 | Year | 06 | Month | 04 | Day |
Anticipated trial start date
| 2019 | Year | 07 | Month | 01 | Day |
Last follow-up date
| 2020 | Year | 06 | Month | 30 | Day |
Date of closure to data entry
| 2020 | Year | 07 | Month | 31 | Day |
Date trial data considered complete
| 2020 | Year | 09 | Month | 30 | Day |
Date analysis concluded
| 2020 | Year | 11 | Month | 30 | Day |
Other
Other related information
Management information
Registered date
| 2019 | Year | 07 | Month | 13 | Day |
Last modified on
| 2023 | Year | 01 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042598
